Researchers at the National University of Singapore have introduced a boron-catalyzed method for transforming oxetanes into 1,3-oxazinanes, which are larger and bioactive molecules.
This process involves the selective insertion of dual atoms, enhancing the molecular architecture and potential medicinal applications of the resulting compounds.
The implications of this advancement could significantly impact the design and synthesis of complex bioactive molecules in pharmaceutical chemistry.